Sumatriptan succinate and Veramyst drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan succinate (sumatriptan succinate) and Veramyst (fluticasone furoate). Common drug interactions include fibula fracture among females and benign prostatic hyperplasia among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan succinate and Veramyst. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan succinate?

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.

What is Veramyst?

Veramyst has active ingredients of fluticasone furoate. It is often used in allergies. eHealthMe is studying from 3,444 Veramyst users. Check the latest studies of Veramyst.



On Jul, 13, 2026

11 people who take Sumatriptan succinate and Veramyst together, and have interactions are studied.

Sumatriptan succinate and Veramyst drug interactions.

What are the common drug interactions of Sumatriptan Succinate and Veramyst, by gender? *:

female:

  1. Fibula fracture
  2. Ligament sprain (ligament stretched)
  3. Osteoporosis (bones weak and more likely to break)
  4. Blood calcium decreased
  5. Bone density decreased
  6. Bone disorder
  7. Dehydration (dryness resulting from the removal of water)
  8. Electrocardiogram qt prolonged
  9. Fracture
  10. Haemoglobin decreased

male:

  1. Benign prostatic hyperplasia (benign enlargement of the prostate)
  2. Hypertension (high blood pressure)
  3. Therapeutic response unexpected
  4. Obesity (having too much body fat)
  5. Gastric bypass
  6. Weight decreased
  7. Xerophthalmia (eye fails to produce tears)

What are the common drug interactions of Sumatriptan Succinate and Veramyst, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Electrocardiogram qt prolonged

40-49:

  1. Ligament sprain (ligament stretched)
  2. Osteoporosis (bones weak and more likely to break)
  3. Blood calcium decreased
  4. Bone density decreased
  5. Bone disorder
  6. Dehydration (dryness resulting from the removal of water)
  7. Fracture
  8. Haemoglobin decreased
  9. Nausea (feeling of having an urge to vomit)
  10. Vomiting

50-59:

  1. Benign prostatic hyperplasia (benign enlargement of the prostate)
  2. Hypertension (high blood pressure)
  3. Therapeutic response unexpected
  4. Obesity (having too much body fat)
  5. Gastric bypass
  6. Weight decreased

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 54.55%
  2. Temporomandibular Joint Syndrome (pain at the temporomandibular joint due to various causes of increased muscle tension and spasm. it is believed that syndrome is a physical manifestation of psychological stress): 3 people, 27.27%
  3. Stress And Anxiety: 3 people, 27.27%
  4. Seasonal Allergy (allergic condition due to certain season): 3 people, 27.27%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 27.27%
  6. Erection Problems: 3 people, 27.27%
  7. Depression: 3 people, 27.27%
  8. Blood Testosterone Decreased: 3 people, 27.27%
  9. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 27.27%
  10. Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan succinate and Veramyst?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sumatriptan succinate and Veramyst:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sumatriptan succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Veramyst:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sumatriptan succinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Veramyst and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate and fluticasone furoate (the active ingredients of Sumatriptan succinate and Veramyst, respectively), and Sumatriptan succinate and Veramyst (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: